| Andrew Wills, | |
|
1111 E End Blvd, Wilkes Barre, PA 18711-0030 | |
| (570) 824-3521 | |
| Not Available |
| Full Name | Andrew Wills |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1111 E End Blvd, Wilkes Barre, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013261387 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 28RI03535200 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Wills, 10c Beaver Ct, Wilkes Barre, PA 18702-7897 Ph: (570) 824-3521 | Andrew Wills, 1111 E End Blvd, Wilkes Barre, PA 18711-0030 Ph: (570) 824-3521 |
News Archive
QLT Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for QLT091001, its oral synthetic retinoid, for the treatment of Leber Congenital Amaurosis (LCA). LCA is an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.
The Chicago Tribune published a series of articles on industry's solutions for health care reform. The paper "turned to Chicago-area leaders in three key segments of the industry: insurers, medical providers and pharmacy," and presented their "thoughts on how best to expand medical-care coverage to all Americans."
In a new research study published in the open access journal PLOS Medicine, Albert Hofman and colleagues at Erasmus MC University Medical Center, Rotterdam, the Netherlands and Harvard T.H. Chan School of Public Health, Boston, United States report that people who experienced substantial changes in blood pressure over the long term were at greater risk of dementia than those who did not.
The bipartisan children's advocacy organization First Focus and PolicyLab at The Children's Hospital of Philadelphia released a new analysis today showing that, five years after its technical end, the recession of the mid-2000s continues to impact America's children.
Phase III results revealed today at The International Liver Congress 2015 show that once-daily treatment with daclatasvir (DCV) plus sofosbuvir (SOF) resulted in an overall 97% sustained virologic response (SVR) at 12 weeks post-treatment in patients with hepatitis C virus (HCV) and HIV co-infection, including cirrhotic patients.
› Verified 9 days ago
Dr. Walter Mieczkowski Iii, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7300 | |
Trina Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 E End Blvd, Wilkes Barre, PA 18711 Phone: 570-824-3521 | |
Stacy Kandrac, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7701 | |
Zachary Connor Schmidt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25 Church St Fl 4, Wilkes Barre, PA 18765 Phone: 570-208-4721 | |
Vanessa Anne Markle, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7754 | |
Mrs. Patricia Ann Wascavage, RPH, MBA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 175 S Wilkes Barre Blvd, Wilkes Barre, PA 18702 Phone: 570-200-7510 Fax: 570-200-7509 |